1. Curcumin: a potential candidate in prevention of cancer via modulation of molecular pathways.
   Arshad H. Rahmani et al, 2014, Biomed Res Int CrossRef
2. Curcumin and its derivatives in breast cancer: Current developments and potential for the treatment of drug-resistant cancers
   Belinda J Cridge et al, 2013, Oncol Discov CrossRef
3. A novel curcumin derivative increases the cytotoxicity of raloxifene in estrogen receptor-negative breast cancer cell lines
   SEBASTIEN TAURIN et al, 2016 CrossRef
4. Targeting the hallmarks of cancer with therapy-induced endoplasmic reticulum (ER) stress
   Abhishek D Garg et al, 2015, Molecular & Cellular Oncology CrossRef
5. Curcuma Contra Cancer? Curcumin and Hodgkin's Lymphoma
   Stefanie Kewitz et al, 2013, Cancer Growth and Metastasis CrossRef
6. Recent advances of curcumin and its analogues in breast cancer prevention and treatment
   Charlotta D. Mock et al, 2015, RSC Adv. CrossRef
7. Therapeutic potential of novel formulated forms of curcumin in the treatment of breast cancer by the targeting of cellular and physiological dysregulated pathways
   Amir Tajbakhsh et al, 2018, J Cell Physiol CrossRef
8. Eliminating the Heart from the Curcumin Molecule: Monocarbonyl Curcumin Mimics (MACs)
   Dinesh Shetty et al, 2014, Molecules CrossRef
9. Curcumin binds tubulin, induces mitotic catastrophe, and impedes normal endothelial cell proliferation
   Steven J.T. Jackson et al, 2013, Food and Chemical Toxicology CrossRef
10. Strategies to target bioactive molecules to subcellular compartments. Focus on natural compounds
    Lucia Biasutto et al, 2019, European Journal of Medicinal Chemistry CrossRef
11. Inhibition of specificity protein 1 by dibenzylideneacetone, a curcumin analogue, induces apoptosis in mucoepidermoid carcinomas and tumor xenografts through Bim and truncated Bid
    Heang-Eun Lee et al, 2014, Oral Oncology CrossRef
12. Pculin02H, a curcumin derivative, inhibits proliferation and clinical drug resistance of HER2-overexpressing cancer cells
    Jin-Cherng Lien et al, 2015, Chemico-Biological Interactions CrossRef
13. null
    A.P. Gupta et al, 2017 CrossRef
14. Cytotoxicity of curcumin derivatives in ALK positive non-small cell lung cancer
    Abigail R. Bland et al, 2019, European Journal of Pharmacology CrossRef
15. Anticancer potential of novel curcumin analogs towards castrate-resistant prostate cancer
    Shuli Chen et al, 2017, Int J Oncol CrossRef
16. Effect of polyphenols on HER2-positive Breast Cancer and related miRNAs: Epigenomic Regulation
    María Eléxpuru Zabaleta et al, 2020, Food Research International CrossRef
17. Modified Curcumins as Potential Drug Candidates for Breast Cancer: An Overview
    Abigail L. Flint et al, 2022, Molecules CrossRef
18. The second‐generation curcumin analogue RL71 elicits G2/M cell cycle arrest and apoptosis in canine osteosarcoma cells
    Barnaby Kelly et al, 2023, Vet Comparative Oncology CrossRef
19. Mechanism insights of curcumin and its analogues in cancer: An update
    Priyanka Joshi et al, 2023, Phytotherapy Research CrossRef
20. Utility of the second-generation curcumin analogue RL71 in canine histiocytic sarcoma
    Barnaby Kelly et al, 2024, Vet Res Commun CrossRef